Senior Principle Scientist
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Biologist by training with main expertise in development of PET based diagnostics and imaging biomarkers, development of imaging strategy to support drug development in oncology as well as implementation of clinical imaging methods with focus on novel approaches, e.g. T cell imaging, radiomics into drug development.
Professional Background
Employed by Boehringer Ingelheim GmbH & Co. KG since 2013 as Medical Imaging Expert working in the Translational Medicine and Clinical Pharmacology department as Senior Principal Scientist mainly for drug development in oncology. Before joining Boehringer Ingelheim I was employed by Bayer Pharma AG and Schering AG working as Principle Scientist in the Department of Diagnostic Research, Molecular Imaging CNS & New Fields as well as Common Mechanism Research, Inflammation.
Since 2020 I'm the co-chair of the Immune Response Imaging Working Group at the Biomarkers Consortium of the FNIH.
